Cancer screening – what you should know

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/cancer-screening-what-you/id43184821... The standard screenings for cancer are for breast, cervical, prostate and colon. For those in a high-risk category, lung, ovarian and liver cancer screenings may be recommended. Therese Bevers, M.D., medical director of Cancer Prevention at MD Anderson Cancer Center, discusses MD Anderson’s cancer screening recommendations and explains the conflicting cancer screening reports.

Combined urology-radiation oncology treatment for prostate cancer patients

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/itunes-u/combined-urology-radiation/id431848... Deborah Kuban, M.D., professor, and Benjamin Smith, M.D., assistant professor, both in Radiation Oncology at MD Anderson, discuss a study examining the emergence of integrated urology-radiation oncology practices in Texas. They discovered prostate cancer patients generally travel further for treatment at the radiation oncology facility owned by their urologist, as opposed to traveling to the...

Fatty acid patterns and risk of prostate cancer in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition

submitted by: ccdahm
Background: Fatty acids in blood may be related to the risk of prostate cancer, but epidemiologic evidence is inconsistent. Blood fatty acids are correlated through shared food sources and common endogenous desaturation and elongation pathways. Studies of individual fatty acids cannot take this into account, but pattern analysis can. Treelet transform (TT) is a novel method that uses data correlation structures to derive sparse factors that explain variation. Objective: The objective...
Authors: Christina Dahm

: Germline Predictors Of Androgen Deprivation Therapy (ADT) Response In Advanced Prostate Cancer

submitted by: WentzMR
Dr. Manish Kohli, Associate Professor of Medical Oncology at Mayo Clinic in Rochester, MN, discusses his article appearing in the March 2012 issue of Mayo Clinic Proceedings, on the association of the TRMT11 gene and prostate cancer and identifying predictive biomarkers. This research may improve prediction of response to hormonal treatments in advanced prostate cancer patients and potentially enhance delivery of individualized medicine in future patients if the findings are validated....

Prostate Health Through Diet and Exercise

submitted by: mdanderson

Please visit: www.mdanderson.org/prevention for more information regarding prevention and screening. Learn how to improve your prostate health through diet and exercise.

Testosterone Supplements and Prostate Cancer

submitted by: mdanderson

Please visit: www.mdanderson.org/prevention for more information regarding prevention and screening. Get the facts on testosterone supplements and prostate cancer.

ACS Guidelines on Testing for Prostate Cancer

submitted by: mdanderson

Please visit: www.mdanderson.org/prevention for more information regarding prevention and screening. Learn what exams and guidelines the American Cancer Society recommends for prostate cancer screening.

Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells

submitted by: mathewsla
BACKGROUND: Recently, much attention has been focused on gaining a better understanding of the different populations of cells within a tumor and their contribution to cancer progression. One of the most commonly used methods to isolate a more aggressive sub-population of cells utilizes cell sorting based on expression of certain cell adhesion molecules. A recently established method we developed is to isolate these more aggressive cells based on their properties of increased invasive...
Authors: Lesley Mathews

Dr Manish Kohli of Mayo Clinic discusses January 2010 Mayo Clinic Proceedings article on prostate cancer

submitted by: mcgheekkm

Dr. Manish Kohli of Mayo Clinic discusses his January 2010 Mayo Clinic Proceedings article (http://tinyurl.com/yk2avz4) on new developments in the medical management of prostate cancer.

Epigenomics of Cancer - Prof. Wei Li (Part 1, 2009)

submitted by: ralanharris

Prof. Wei Li lectures on studies of transcription factor binding sites and histone modifications using ChIP-chip and Chip-seq assays. Part of the Computer Aided Discovery Methods 2009 course offered at Baylor College of Medicine.